Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy

Kendel, Friederike; Helbig, Lukas; Neumann, Konrad; Herden, Jan; Stephan, Carsten; Schrader, Mark; Gaissmaier, Wolfgang

Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy

Dateien

Zu diesem Dokument gibt es keine Dateien.

Datum

2016

Autor:innen

Kendel, Friederike

Helbig, Lukas

Neumann, Konrad

Herden, Jan

Stephan, Carsten

Schrader, Mark

Gaissmaier, Wolfgang

DOI (zitierfähiger Link)

https://doi.org/10.1002/ijc.30123

Sammlungen

Psychologie

Publikationstyp

Zeitschriftenartikel

Publikationsstatus

Published

Erschienen in

International Journal of Cancer. 2016, 139(4), pp. 749-753. ISSN 0020-7136. eISSN 1097-0215. Available under: doi: 10.1002/ijc.30123

Zusammenfassung

Treatment choice for localized prostate cancer (PCa) is a controversial issue, and mortality risk is probably the most decisive factor in this regard. The study aimed to compare prostate-cancer-specific mortality risk estimates for different treatment options assigned by patients managed with active surveillance (AS), radical prostatectomy (RP), and patients who had discontinued AS (DAS). We matched patients initially managed with AS or RP (N = 370) according to length of therapy. Patients completed mailed questionnaires assessing their mortality risk estimates (in %) and prostate-cancer-specific anxiety. We analyzed differences in risk estimates among the three treatment groups using ANOVA, relationships of clinical and psychosocial variables with risk estimates using standard multiple regression. In all treatment groups, the prostate- cancer-specific mortality risk was overestimated. This applied whether it was the patient's own treatment or the alternative treatment option. RP patients assigned a mortality risk to AS that was almost three times higher than that assigned to RP (50.9±25.0 vs. 17.8±19.7, d = 1.48; p <.001). Anxiety was significantly associated with risk estimates for AS (p = .008) and RP (p = .001). Compared to clinical data that suggest that the prostate-cancer-specific mortality risk for AS is low and does not significantly differ from that for RP, patients strongly overestimated the mortality risk. This was most markedly so in RP patients, who drastically overestimated the benefits of RP compared to the risk of AS. This overestimation could increase overtreatment and should therefore be corrected by better patient education. This article is protected by copyright. All rights reserved.

Fachgebiet (DDC)

150 Psychologie

Zitieren

ISO 690

KENDEL, Friederike, Lukas HELBIG, Konrad NEUMANN, Jan HERDEN, Carsten STEPHAN, Mark SCHRADER, Wolfgang GAISSMAIER, 2016. Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy. In: International Journal of Cancer. 2016, 139(4), pp. 749-753. ISSN 0020-7136. eISSN 1097-0215. Available under: doi: 10.1002/ijc.30123

BibTex

@article{Kendel2016-08-15Patie-34167,
  year={2016},
  doi={10.1002/ijc.30123},
  title={Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy},
  number={4},
  volume={139},
  issn={0020-7136},
  journal={International Journal of Cancer},
  pages={749--753},
  author={Kendel, Friederike and Helbig, Lukas and Neumann, Konrad and Herden, Jan and Stephan, Carsten and Schrader, Mark and Gaissmaier, Wolfgang}
}

RDF

<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/34167">
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/34167"/>
    <dc:creator>Kendel, Friederike</dc:creator>
    <dc:creator>Herden, Jan</dc:creator>
    <dc:creator>Schrader, Mark</dc:creator>
    <dc:contributor>Stephan, Carsten</dc:contributor>
    <dc:contributor>Helbig, Lukas</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Kendel, Friederike</dc:contributor>
    <dcterms:abstract xml:lang="eng">Treatment choice for localized prostate cancer (PCa) is a controversial issue, and mortality risk is probably the most decisive factor in this regard. The study aimed to compare prostate-cancer-specific mortality risk estimates for different treatment options assigned by patients managed with active surveillance (AS), radical prostatectomy (RP), and patients who had discontinued AS (DAS). We matched patients initially managed with AS or RP (N = 370) according to length of therapy. Patients completed mailed questionnaires assessing their mortality risk estimates (in %) and prostate-cancer-specific anxiety. We analyzed differences in risk estimates among the three treatment groups using ANOVA, relationships of clinical and psychosocial variables with risk estimates using standard multiple regression. In all treatment groups, the prostate- cancer-specific mortality risk was overestimated. This applied whether it was the patient's own treatment or the alternative treatment option. RP patients assigned a mortality risk to AS that was almost three times higher than that assigned to RP (50.9±25.0 vs. 17.8±19.7, d = 1.48; p &lt;.001). Anxiety was significantly associated with risk estimates for AS (p = .008) and RP (p = .001). Compared to clinical data that suggest that the prostate-cancer-specific mortality risk for AS is low and does not significantly differ from that for RP, patients strongly overestimated the mortality risk. This was most markedly so in RP patients, who drastically overestimated the benefits of RP compared to the risk of AS. This overestimation could increase overtreatment and should therefore be corrected by better patient education. This article is protected by copyright. All rights reserved.</dcterms:abstract>
    <dc:contributor>Neumann, Konrad</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-06-01T08:19:06Z</dcterms:available>
    <dc:contributor>Schrader, Mark</dc:contributor>
    <dc:creator>Stephan, Carsten</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/>
    <dc:contributor>Herden, Jan</dc:contributor>
    <dc:creator>Gaissmaier, Wolfgang</dc:creator>
    <dcterms:title>Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy</dcterms:title>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Helbig, Lukas</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-06-01T08:19:06Z</dc:date>
    <dc:creator>Neumann, Konrad</dc:creator>
    <dc:contributor>Gaissmaier, Wolfgang</dc:contributor>
    <dc:language>eng</dc:language>
    <dcterms:issued>2016-08-15</dcterms:issued>
  </rdf:Description>
</rdf:RDF>

Universitätsbibliographie

Ja